UBS Group
DXCM icon

UBS Group’s DexCom DXCM Stock Holding History

UBS Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Sell
224,700
-268,396
-54% -$17.9M ﹤0.01% 2983
2026
Q1 		$31M Sell
493,096
-275,200
-36% -$19.2M ﹤0.01% 2135
2025
Q4 		$51M Buy
768,296
+108,796
+16% +$7.03M 0.01% 1608
2025
Q3 		$44.4M Buy
659,500
+297,300
+82% +$23.5M 0.01% 1756
2025
Q2 		$31.6M Sell
362,200
-74,000
-17% -$5.8M 0.01% 1924
2025
Q1 		$29.8M Buy
436,200
+82,600
+23% +$6.74M 0.01% 1959
2024
Q4 		$27.5M Sell
353,600
-80,400
-19% -$5.95M 0.01% 1995
2024
Q3 		$29.1M Buy
434,000
+188,740
+77% +$15.5M 0.01% 1546
2024
Q2 		$27.8M Buy
245,260
+7,600
+3% +$961K 0.01% 1423
2024
Q1 		$33M Buy
237,660
+54,700
+30% +$6.88M 0.01% 1329
2023
Q4 		$22.7M Sell
182,960
-181,240
-50% -$18.5M 0.01% 1511
2023
Q3 		$34M Buy
364,200
+172,800
+90% +$19.5M 0.01% 1096
2023
Q2 		$24.6M Buy
191,400
+120,500
+170% +$14.6M 0.01% 1293
2023
Q1 		$8.24M Sell
70,900
-26,522
-27% -$2.97M ﹤0.01% 2051
2022
Q4 		$11M Buy
+97,422
New +$10.7M ﹤0.01% 1847
2015
Q3 		– Sell
-26,800
Closed -$536K – 8453
2015
Q2 		$536K Buy
+26,800
New +$471K ﹤0.01% 4065
2015
Q1 		– Sell
-400
Closed -$6K – 8934
2014
Q4 		$6K Buy
+400
New +$4.9K ﹤0.01% 8820

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

UBS Group's DXCM Position: Q2 2026 in Review

UBS Group increased its DexCom (DXCM) stake by 39% in Q2 2026, buying an estimated $114M and bringing the position to 6,065,779 shares worth $409M. The position accounts for 0.05% of the portfolio, ranked #370.

UBS Group first reported a position in DXCM in Q4 2014 and has held it in 47 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • UBS Group held 6,065,779 shares of DexCom worth $409M as of Q2 2026.
  • UBS Group bought 1,715,820 DexCom shares in Q2 2026, an estimated $114M.
  • DexCom made up 0.05% of UBS Group's portfolio in Q2 2026, its #370 holding.
  • UBS Group first reported a position in DexCom in Q4 2014 and has held it in 47 quarters since.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.